Work

Alk Inhibitor Ap26113 in Patients with Advanced Malignancies, Including Alk+ Non-Small Cell Lung Cancer (Nsclc): Updated Efficacy and Safety Data

Year: 2014

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu349.71

Authors: S. Gettinger, L. Bazhenova, R. Salgia, C. Langer, K. Gold, R. Rosell, A. Shaw, G.J. Weiss, N.I. Narasimhan, D.J. Dorer, V.M. Rivera, T. Clackson, F.G. Haluska, R. Camidge

Institutions: Yale University, University of California San Diego, Moores Cancer Center, University of Chicago, Abramson Cancer Center, University of Pennsylvania, The University of Texas MD Anderson Cancer Center, Instituto Oncológico Dr. Rosell, USP Institut Universitari Dexeus, Massachusetts General Hospital, ARIAD Pharmaceuticals (United States), University of Colorado Denver

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2185920764

FWCI: 3.633

Cites: 8

Cited by: 17

Related to: 10